A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood – ...

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Aldrich, 61, has also played with the likes of Lion, Hurricane, House of Lords, Bad Moon Rising and Revolution Saints. Also, ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.

“The FDA approval of OSPOMYV and XBRYK marks a key step in improving patient access and alleviating treatment cost for patients with osteoporosis and cancer-related ... and in patients with bone ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...